BIOMAT Database Logo BIOMAT Database Logo

Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents. 2010

Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
School of Medicine, Xi'an Jiaotong University, Xi'an, 710061, P.R. China.

Antiangiogenic therapy might represent a new promising anticancer therapeutic strategy. Taspine can significantly inhibit cell proliferation of human umbilical vein endothelial cells (HUVECs) induced by vascular endothelial growth factor-165, which is crucial for angiogenesis. In this study, a series of novel taspine derivatives were synthesized and screened for in vitro anticancer and antiangiogenesis activities. The majority of the derivatives demonstrated a moderate degree of cytotoxicity against human cancer cell lines. One of them (14) exhibited much better antiproliferative activity against CACO-2 (IC(50)=52.5microM) and ECV304 (IC(50)=2.67microM) cells than taspine did. Some of them were also effective in antiproliferative assays against HUVECs. The in silico estimate of solubility of title compounds were higher than that of taspine.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic
D040301 Vascular Endothelial Growth Factor Receptor-2 A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF. VEGFR-2,Fetal Liver Kinase-1,Flk-1 Protein,Flk-1 Receptor Tyrosine Kinase,KDR Tyrosine Kinase,Kinase Insert Domain Receptor,VEGF Receptor Flk-1,VEGF Receptor KDR,Fetal Liver Kinase 1,Flk 1 Protein,Flk 1 Receptor Tyrosine Kinase,Flk-1, VEGF Receptor,KDR, VEGF Receptor,Tyrosine Kinase, KDR,VEGF Receptor Flk 1,Vascular Endothelial Growth Factor Receptor 2

Related Publications

Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis and biological evaluation of novel dibenzofluorene derivatives as anticancer agents.
March 2010, Oncology letters,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis and biological evaluation of novel anthranilamide derivatives as anticancer agents.
August 2013, Drug discoveries & therapeutics,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
January 2015, European journal of medicinal chemistry,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents.
July 2019, Bioorganic & medicinal chemistry letters,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis and biological evaluation of novel demethylzeylasteral derivatives as potential anticancer agents.
June 2023, Fitoterapia,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Novel 2-Aminobenzothiazole Derivatives: Docking, Synthesis, and Biological Evaluation as Anticancer Agents.
March 2024, ACS omega,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
January 2018, Chemical & pharmaceutical bulletin,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis and biological evaluation of novel withangulatin A derivatives as potential anticancer agents.
March 2021, Bioorganic chemistry,
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as possible anticancer agents.
December 2020, Acta pharmaceutica (Zagreb, Croatia),
Jie Zhang, and Yanmin Zhang, and Yuanyuan Shan, and Na Li, and Wei Ma, and Langchong He
Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents.
June 2021, Bioorganic chemistry,
Copied contents to your clipboard!